In a Canadian hospital, laparoscopic liver resection provides cost avoidance for hepatocellular carcinoma or secondary colorectal metastases when compared to open resection.
THE UTILIZATION OF LAPAROSCOPIC VERSUS OPEN LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA OR SECONDARY COLORECTAL METASTASES: A BUDGET IMPACT ANALYSIS
In a Canadian hospital, laparoscopic liver resection provides cost avoidance for hepatocellular carcinoma or secondary colorectal metastases when compared to open resection.
Clinical research has demonstrated that laparoscopic liver resection for hepatocellular carcinoma (HCC) or secondary colorectal metastases (CRM) provides oncologically equivalent outcomes when compared to open liver resection, while also providing a statistically significant reduction in postoperative complications. Laparoscopic liver resections are associated with higher device costs, but this is offset by a shorter length of stay of 3.2 days with a diagnosis of HCC and 2.3 days for a diagnosis of CRM. The inpatient cost for one laparoscopic liver resection with a diagnosis of CRM is $3,497 less than an open resection (see Table 1 .0 for detailed cost breakdown). Similarly, the inpatient cost for one laparoscopic liver resection with a diagnosis of HCC is $4,616 less than for an open resection. Additionally, a reduced incidence of surgical complications is associated with laparoscopic liver resection. For HCC a meta-analysis found a reduced incidence of blood transfusions (from 4.8% to 2.5%), postoperative ascites (from 6.4% to 2.1%) and liver failure (from 4.0% to 0.3%) (see Table 2 .0 for incidence and costs of complications for HCC). For CRM, a meta-analysis found a reduced incidence of blood transfusions (from 19.8% to 9.9%). The model establishes that for a Canadian hospital performing 50 liver resections increasing the proportion of laparoscopic cases from 16% to 40% allows for a potential cost avoidance of CAD $50,730 annually.
Incidence in lap liver resection
Incidence in open liver resection
Cost of complications
Blood transfusions 2.50%* 4.80% $320
Postoperative ascites 2.10%* 6.40% $6,170
Liver failure 0.3%* 4% $29,290 
